PAI-1-targeted monoclonal antibody (MedImmune)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePAI-1-targeted monoclonal antibody (MedImmune)
Drug Alias NamePAI-1 modulator (MedImmune)Plasminogen Activator Inhibitor-1 Modulator (MedImmune)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionPlasminogen activator inhibitor 1 modulators
TargetsPlasminogen activator inhibitor 1
Therapy Area/IndicationsCardiovascular DiseasesPulmonary Disease, Chronic ObstructiveGastrointestinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedimmune Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedimmune Llc
Active IndicationsN/A
Inactive IndicationsCardiovascular DiseasesPulmonary Disease, Chronic ObstructiveGastrointestinal Diseases

Other Information

ATC CodeN/A
Related LinksN/A